Skip to main content

Table 1 Summary of the results of laboratory findings on presentation

From: Fulminant hepatic failure in a patient testing re-positive for SARS-CoV-2: a case report

Laboratory investigation Result Reference range
Hematological profile Hemoglobin (g/dL) 11.4 13.0–18.0
White blood cell (1000/μL) 9.8 4.0–11.0
Platelet (1000/μL) 448 140–450
Neutrophils (%) 75.4 40–60
Lymphocytes (%) 11.0 20–40
Hepatic profile Total bilirubin (mg/dL) 1.3 0.2–1.2
Albumin (g/dL) 4.0 3.4–5.0
Alkaline phosphatase (U/L) 150 46–116
γ-Glutamyltransferase (U/L) 49 15–85
Alanine transferase (U/L) 2,411 14–63
Aspartate transferase (U/L) 2,466 15–37
Coagulation profile Prothrombin time (s) >120 12.9–15.9
Partial thromboplastin time (s) 120 25.6–42.3
International normalized ratio >15.8 0.8–1.1
Inflammatory profile C-Reactive protein (mg/dL) <0.10 0.10–0.50
Lactic acid (mmol/L) 19.7 0.5–2.2
Ferritin (ng/ml) 165.2 4.6–204.0
Serology profile Hepatitis A IgM antibody Negative Negative
Hepatitis B core antibody Negative Negative
Hepatitis B surface antibody Negative Negative
Hepatitis C virus antibody Negative Negative
Ebstein-Barr virus IgM antibody Negative Negative
Cytomegalovirus IgM antibody Negative Negative
Human immunodeficiency virus antibody Negative Negative
Autoimmune profile Antimitochondrial antibody Negative Negative
Antinuclear antibody Negative Negative
Anti-liver/kidney microsomal antibody Negative Negative
Anti-smooth-muscle antibody Negative Negative
Toxicology profile Acetaminophen Negative Negative
Tetrahydrocannabinol Negative Negative
Benzodiazepines Negative Negative